Literature DB >> 10071095

Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease.

M Seipelt1, I Zerr, R Nau, B Mollenhauer, S Kropp, B J Steinhoff, C Wilhelm-Gössling, C Bamberg, R W Janzen, P Berlit, F Manz, K Felgenhauer, S Poser.   

Abstract

OBJECTIVES: During an epidemiological study of Creutzfeldt-Jakob disease in Germany, Hashimoto's encephalitis was encountered as a differential diagnosis, which has not yet been described in this context.
METHODS: The symptoms and findings of seven patients who fulfilled the criteria for "possible" Creutzfeldt-Jakob disease are presented.
RESULTS: A Hashimoto's thyroiditis with antibodies against thyroglobulin or thyroid peroxidase, or both and a hypoechoic thyroid ultrasonogram were found in all cases. Analysis of CSF disclosed an increased leucocyte count in three patients, and a raised CSF:serum concentration ratio of albumin (QA1b) in four patients. The 14-3-3 protein, typical of Creutzfeldt-Jakob disease, could not be detected in any of our patients. No periodic sharp wave complexes, which are typical of Creutzfeldt-Jakob disease, were detected on EEG in any of the cases. By contrast with Creutzfeldt-Jakob disease, which leads to death within a few months, the patients with Hashimoto's encephalitis often recover quickly when treated adequately. All the patients improved after administration of corticosteroids.
CONCLUSION: The clinical symptomatology of both diseases may be very similar: dementia, myoclonus, ataxia, and personality change or psychotic phenomena are characteristic symptoms.

Entities:  

Mesh:

Year:  1999        PMID: 10071095      PMCID: PMC1736201          DOI: 10.1136/jnnp.66.2.172

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  [Hashimoto's encephalopathy: toxic or autoimmune mechanism?].

Authors:  F Ghawche; R Bordet; A Destée
Journal:  Rev Neurol (Paris)       Date:  1992       Impact factor: 2.607

Review 2.  [Isolated angiitis of the CNS associated with Hashimoto's disease].

Authors:  N Shibata; Y Yamamoto; N Sunami; M Suga; Y Yamashita
Journal:  Rinsho Shinkeigaku       Date:  1992-02

Review 3.  Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases.

Authors:  P J Shaw; T J Walls; P K Newman; P G Cleland; N E Cartlidge
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

4.  Hashimoto encephalopathy: etiologic considerations.

Authors:  S Takahashi; R Mitamura; Y Itoh; N Suzuki; A Okuno
Journal:  Pediatr Neurol       Date:  1994-11       Impact factor: 3.372

5.  Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; O Gefeller; M Otto; S Poser; J Wiltfang; O Windl; H A Kretzschmar; T Weber
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

6.  Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.

Authors:  P Brown; C J Gibbs; P Rodgers-Johnson; D M Asher; M P Sulima; A Bacote; L G Goldfarb; D C Gajdusek
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

7.  Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease.

Authors:  B J Steinhoff; S Räcker; G Herrendorf; S Poser; S Grosche; I Zerr; H Kretzschmar; T Weber
Journal:  Arch Neurol       Date:  1996-02

8.  Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; S Räcker; S Grosche; S Poser; H A Kretzschmar; T Weber
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

9.  Electroencephalographic findings in Hashimoto's encephalopathy.

Authors:  R Henchey; J Cibula; W Helveston; J Malone; R L Gilmore
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

10.  Case report: thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto's encephalopathy.

Authors:  K Ishii; A Hayashi; A Tamaoka; S Usuki; H Mizusawa; S Shoji
Journal:  Am J Med Sci       Date:  1995-11       Impact factor: 2.378

View more
  20 in total

1.  MR findings in Hashimoto encephalopathy.

Authors:  Yonung Min Song; Dae Won Seo; Gregory Youngnam Chang
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

2.  Hashimoto encephalopathy: a do-not-miss in the differential diagnosis of dementia.

Authors:  Claire J Creutzfeldt; Roman L Haberl
Journal:  J Neurol       Date:  2005-06-13       Impact factor: 4.849

3.  14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy.

Authors:  T Vander; C Hallevy; I Alsaed; S Valdman; G Ifergane; I Wirguin
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 4.  The neurological disorder associated with thyroid autoimmunity.

Authors:  Franco Ferracci; Antonio Carnevale
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

5.  A 54-year-old man with slowness of movement and confusion.

Authors:  Michael D Geschwind; Keith A Josephs; Joseph E Parisi; B Mark Keegan
Journal:  Neurology       Date:  2007-11-06       Impact factor: 9.910

Review 6.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Hashimoto's encephalopathy: an under diagnosed entity.

Authors:  Anil Bhansali; P Jayaprakash; Pinaki Dutta; Rama Walia; R Anantharaman; M Modi
Journal:  BMJ Case Rep       Date:  2009-05-08

8.  [Organic schizophreniform disorder with pre-existing autoimmune thyroiditis].

Authors:  E Gruber; C Algermissen; H Ebel
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

Review 9.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

10.  [Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].

Authors:  C Laske; T Leyhe; G Buchkremer; H Wormstall
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.